Equities Analysts Offer Predictions for Vaxart Q3 Earnings
Vaxart, Inc. (NASDAQ:VXRT – Free Report) – Investment analysts at B. Riley boosted their Q3 2025 EPS estimates for Vaxart in a report issued on Thursday, May 29th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will earn ($0.04) per share for the quarter, up from their previous estimate of ($0.07). B. […]
Vaxart, Inc. (NASDAQ:VXRT – Free Report) – Investment analysts at B. Riley boosted their Q3 2025 EPS estimates for Vaxart in a report issued on Thursday, May 29th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will earn ($0.04) per share for the quarter, up from their previous estimate of ($0.07). B. […]
